awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38074121-4855A508-31FD-41A5-92C5-649A63FC8437
Q38074121-4855A508-31FD-41A5-92C5-649A63FC8437
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38074121-4855A508-31FD-41A5-92C5-649A63FC8437
Targeting PI3K and mTORC2 in metastatic renal cell carcinoma: new strategies for overcoming resistance to VEGFR and mTORC1 inhibitors.
P2860
Q38074121-4855A508-31FD-41A5-92C5-649A63FC8437
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38074121-4855A508-31FD-41A5-92C5-649A63FC8437
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
97e6971c90f641178518b456e65c533735b1ecf5
P2860
Phase I, dose-escalation study of BKM120, an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors.